Literature DB >> 23037201

High serum levels of both carcinoembryonic antigen and carbohydrate antigen 19-9 in a patient with sigmoid colon cancer without metastasis.

Hajime Nakatani1, Tatsuya Kumon, Masamitsu Kumon, Shinichi Hamada, Toyotake Okanoue, Akihiro Kawamura, Kimiko Nakatani, Makoto Hiroi, Kazuhiro Hanazaki.   

Abstract

Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA)19-9 are well known as the most common tumor markers of colon cancer, and levels are used not only for preoperative assessment of extent and outcome of cancer, but also postoperative monitoring of recurrence. We encountered a patient with sigmoid colon cancer showing abnormally high serum levels of CEA (311.1 ng/ml) and CA19-9 (5731.2 U/ml) preoperatively. We could not detect any metastases on computed tomography (CT) or (18)F-fluorodeoxyglucose positron emission tomography/CT. Sigmoidectomy and lymph node dissection were performed. Pathological analysis revealed well-differentiated tubular adenocarcinoma of the sigmoid colon with cancer cells infiltrating to the subserosa, but no lymph node metastases. As of postoperative day 60, serum levels of CEA and CA19-9 were 3.4 ng/ml and 9.2 U/ml, respectively, without any further anti-tumor treatment. This represents a rare case of sigmoid colon cancer with high levels of tumor markers in sera that improved following sigmoidectomy without further anti-cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23037201     DOI: 10.2152/jmi.59.280

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  6 in total

1.  Sensitivity of Symptomatology Versus Diagnostic Procedures and Concentration of CEA and CA19-9 in the Early Detection of Colorectal Cancer.

Authors:  Zora Vukobrat-Bijedic; Azra Husic-Selimovic; Nina Bijedic; Admir Mujkic; Amela Sofic; Bisera Gogov; Amila Mehmedovic; Ivana Bjelogrlic; Sanjin Glavas; Aleksandra Djuran
Journal:  Acta Inform Med       Date:  2014-04

2.  Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma.

Authors:  Zora Vukobrat-Bijedic; Azra Husic-Selimovic; Amela Sofic; Nina Bijedic; Ivana Bjelogrlic; Bisera Gogov; Amila Mehmedovic
Journal:  Med Arch       Date:  2013-12-28

Review 3.  Biochemical Markers of Colorectal Cancer - Present and Future.

Authors:  Wojciech Jelski; Barbara Mroczko
Journal:  Cancer Manag Res       Date:  2020-06-22       Impact factor: 3.989

4.  Evaluation of the Biological Efficiency of Silver Nanoparticles Biosynthesized Using Croton tiglium L. Seeds Extract against Azoxymethane Induced Colon Cancer in Rats.

Authors:  Wael Mahmoud Aboulthana; Noha El-Sayed Ibrahim; Noha Mohamed Osman; Mohamed Mahmoud Seif; Amgad Kamal Hassan; Ahmed Mahmoud Youssef; Amal Mostafa El-Feky; A A Madboli
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

5.  Assessment of the Anti-Cancer Efficiency of Silver Moringa oleifera Leaves Nano-extract against Colon Cancer Induced Chemically in Rats.

Authors:  Wael Mahmoud Aboulthana; Wafaa Ghoneim Shousha; Ehab Abdel-Raouf Essawy; Mahmoud Hosny Saleh; Alaa Hamed Salama
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

6.  Clinical significance of golgi protein-73 as a diagnostic marker for Egyptian patients with colorectal cancer: Preliminary study.

Authors:  Shaymaa Abdelraheem Abdelhady; Heba Attya; Mohamed Abdo; Fadia M Attia
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.